Find Paid Clinical Trials in France

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in France

Top of Directory » All Locations » France


  • Bacterial Colonization After Tunneling in Femoral Perineural Catheters

    Condition:   Bacterial Colonization
    Intervention:   Procedure: tunnelized perineural catheter
    Sponsor:   University Hospital, Rouen
    Not yet recruiting - verified November 2009

  • Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System (IPSS) Low-risk and Intermediate-1 Myelodysplastic Syndrome (MDS) Patients, Resistant to Erythropoetin-stimulating Agents (ESA)

    Condition:   Myelodysplastic Syndromes
    Interventions:   Drug: Azacitidine;   Drug: Epoetin beta
    Sponsors:   Groupe Francophone des Myelodysplasies;   Celgene Corporation;   Roche Pharma AG
    Recruiting - verified November 2009

  • Place of Antibiotics in the Postoperative Acute Lithiasic Cholecystitis

    Conditions:   Acute Lithiasic Cholecystitis Grade I or II;   Symptoms Lasting for Less Than 5 Days;   Required Cholecystectomy;   Preoperative Amoxicillin Clavulanic Acid for at Most 5 Days
    Interventions:   Drug: amoxicillin clavulanic acid;   Drug: No medication
    Sponsor:   Centre Hospitalier Universitaire, Amiens
    Not yet recruiting - verified November 2009

  • Prospective Randomized Study Comparing One or Two High Dose Chemotherapy Regimen Followed by Autologous Stem Cell Transplantation

    Condition:   Acute Myeloid Leukemia
    Interventions:   Drug: Zavedos;   Drug: Cerubidine
    Sponsor:   Nantes University Hospital
    Completed - verified November 2009

  • Assessment of the Nociception During Lumbar Surgery

    Condition:   Lumbar Surgery
    Interventions:   Drug: remifentanil;   Drug: remifentanil
    Sponsor:   University Hospital, Grenoble
    Recruiting - verified November 2009

  • Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: Amorolfine (Antifungal);   Drug: RV4104A, Ciclopiroxolamine, Cyclopirox (Keratolytic Agents/Antifungal)
    Sponsors:   Pierre Fabre Dermo Cosmetique;   QUANTA MEDICAL
    Recruiting - verified November 2009

  • Impact of Heart Failure on Calcium Homeostasis and Mitochondrial Function in Human Skeletal Muscle

    Condition:   Heart Failure
    Intervention:  
    Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   Direction de l'Hospitalisation et de l'Offre de Soins (DHOS), France;   Institut National du CAncer (INCA), France;   Institut de Recherches Internationales Servier, France
    Not yet recruiting - verified November 2009

  • Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention

    Conditions:   Uterine Cervical Neoplasms;   Uterine Cervical Dysplasia
    Intervention:   Other: Screening test
    Sponsor:   University Hospital, Tours
    Recruiting - verified November 2009

  • Recruitment Maneuver After Intubation

    Condition:   Hypoxemia
    Intervention:   Other: Recruitment maneuver
    Sponsor:   University Hospital, Clermont-Ferrand
    Recruiting - verified November 2009

  • Functional Neuroimaging of Postural Reconstruction

    Condition:   Healthy
    Intervention:   Radiation: SPECT : ECD-Tc99m - Neurolite, Bristol-Myers Squibb Medical Imaging
    Sponsor:   University Hospital, Strasbourg, France
    Recruiting - verified November 2009

  • An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

    Condition:   Hepatitis B, Chronic
    Intervention:  
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantation

    Condition:   Liver Transplantation
    Interventions:   Drug: Advagraf;   Drug: Mycophenolate Mofetil;   Drug: Basiliximab;   Drug: Corticosteroids
    Sponsor:   Astellas Pharma Inc
    Recruiting - verified November 2009

  • Human Anaplasmosis in Eastern France

    Conditions:   Anaplasmosis;   Tick-Borne Disease;   Ehrlichia
    Intervention:   Procedure: Blood sampling
    Sponsor:   University Hospital, Strasbourg, France
    Not yet recruiting - verified November 2009

  • Linagliptin 2.5 mg Twice Daily Versus 5 mg Once Daily as add-on Therapy to Twice Daily Metformin in Type 2 Diabetes

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: linagliptin;   Drug: placebo
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified November 2009

  • A Phase IIb 78-week Study in Patients on a Basal Insulin +/- Metformin and/or Sulfonylurea and Are Not at Goal to Add BI 10773 vs. Placebo

    Condition:   Diabetes Mellitus, Type 2
    Intervention:   Drug: BI 10773
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified November 2009

  • Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients

    Conditions:   Chronic Renal Failure;   Hemodialysis
    Interventions:   Drug: nicotinamide;   Drug: sevelamer;   Drug: cinacalcet
    Sponsor:   Centre Hospitalier Universitaire, Amiens
    Not yet recruiting - verified November 2009

  • Docetaxel With a Phytochemical in Treating Patients With Hormone Independent Metastatic Prostate Cancer

    Condition:   Metastatic Prostate Cancer
    Interventions:   Dietary Supplement: phytochemical;   Drug: Docetaxel
    Sponsor:   Centre Jean Perrin
    Recruiting - verified November 2009

  • Utilisation of Angiox® in European Practice

    Conditions:   Stable Angina (SA);   NSTE-ACS (NSTEMI and UA);   Stemi (Ste-acs)
    Intervention:  
    Sponsor:   The Medicines Company
    Recruiting - verified November 2009

  • Procalcitonin in Pleural Pleuritis

    Conditions:   Pleuritis;   Pleural Empyema
    Intervention:   Other: pleural level of procalcitonin
    Sponsor:   Centre Hospitalier Universitaire, Amiens
    Recruiting - verified November 2009

  • Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma

    Condition:   Thymic Carcinoma
    Intervention:   Drug: PHA-848125AC
    Sponsor:   Nerviano Medical Sciences
    Not yet recruiting - verified November 2009

  • BIBF 1120 or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer

    Conditions:   Ovarian Neoplasms;   Peritoneal Neoplasms
    Interventions:   Drug: BIBF 1120;   Drug: Placebo
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Not yet recruiting - verified November 2009

  • Study Comparing Reduction and Viral Safety of IFN Alfa-2b XL + Ribavirin Versus PEG IFN Alfa-2b + Ribavirin in Patients With Chronic Hepatitis C Genotype 1

    Condition:   Chronic Hepatitis C
    Interventions:   Drug: IFN alfa-2b XL 27 MUI + Ribavirin;   Drug: IFN alfa-2b XL 36 MUI + Ribavirin;   Drug: IFN peg alfa-2b 1.5 µg/kg + Ribavirin
    Sponsor:   French National Agency for Research on AIDS and Viral Hepatitis
    Not yet recruiting - verified November 2009

  • A Study of RO5072759 With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

    Condition:   Lymphocytic Leukemia, Chronic
    Interventions:   Drug: RO5072759;   Drug: rituximab;   Drug: chlorambucil
    Sponsors:   Hoffmann-La Roche;   Genentech
    Not yet recruiting - verified November 2009

  • Determination of New Biomarkers of Septic Arthritis by Surface-Enhanced Laser Desorption/Ionization Time-Of-Flight (SELDI-TOF)

    Condition:   Acute Arthritis
    Intervention:  
    Sponsor:   University Hospital, Grenoble
    Recruiting - verified November 2009

  • Cardiopulmonary Resuscitation Witnessing by a Relative

    Condition:   Cardiac Arrest - Post-traumatic Stress Disorder
    Interventions:   Other: Usual strategy;   Other: Modified strategy
    Sponsors:   Assistance Publique - Hôpitaux de Paris;   Ministry of Health, France
    Not yet recruiting - verified November 2009

  • Clinical Trial to Compare the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine to a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)

    Condition:   HIV Infections
    Interventions:   Biological: adjuvanted A(H1N1)v influenza vaccine;   Biological: non-adjuvanted A(H1N1)v influenza vaccine
    Sponsors:   French National Agency for Research on AIDS and Viral Hepatitis;   GlaxoSmithKline
    Active, not recruiting - verified November 2009

  • Prospective Multicentric Study of Cytomegalovirus Resistance in Transplant Patients and Bone Marrow Recipients

    Condition:   Cytomegalovirus
    Intervention:   Biological: depistage
    Sponsor:   University Hospital, Limoges
    Recruiting - verified November 2009

  • Multipolar Radiofrequency Ablation for Hepatocellular Carcinoma Using Extra Nodular Versus Intranodular Technique

    Condition:   Hepatocellular Carcinomas
    Intervention:   Procedure: Radiofrequency ablation
    Sponsor:   Assistance Publique - Hôpitaux de Paris
    Not yet recruiting - verified November 2009

  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma

    Condition:   Prostate Cancer
    Interventions:   Drug: cyproterone acetate;   Drug: Venlafaxine;   Drug: -Medroxyprogesterone
    Sponsor:   Laboratoires Takeda
    Completed - verified November 2009

  • A Study Comparing LEO 80190 Ointment With Hydrocortisone Ointment, Both Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and Intertriginous Areas

    Condition:   Psoriasis Vulgaris
    Interventions:   Drug: LEO 80190;   Drug: Hydrocortisone
    Sponsor:   LEO Pharma
    Recruiting - verified November 2009

  • Low-energy Laser Therapy for Prevention of Oral Mucositis in Children

    Condition:   Oral Mucositis
    Intervention:   Device: LLLT :low level laser therapy
    Sponsors:   University Hospital, Clermont-Ferrand;   - Centre Régional de Cancérologie et Thérapie Cellulaire Pédiatrique, CHU de Clermont-Ferrand;   - Faculté de chirurgie dentaire, Clermont-Ferrand;   - Centre de Pharmacologie Clinique, INSERM CIC 501;   - Laboratoire des Matériaux Inorganiques, ESA CNRS 6002 et ENSCCF, Université Blaise-Pascal, Aubière
    Recruiting - verified November 2009

  • Observational Study of Patient Comprehension, Perception, Fears and Appreciation Following Home-Monitoring Implementation

    Conditions:   Defibrillators;   Tachycardia
    Intervention:   Other: Remote monitoring by Home Monitoring system
    Sponsors:   Biotronik France;   Biotronik SE & Co. KG
    Recruiting - verified November 2009

  • Factors Determining Quality of Life Related to Respiratory Status According to Gender of Chronic Obstructive Pulmonary Disease (COPD) Patients

    Condition:   Chronic Obstructive Pulmonary Disease
    Intervention:  
    Sponsor:   AstraZeneca
    Recruiting - verified November 2009

  • Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

    Condition:   Retinal Vein Occlusion
    Interventions:   Drug: VEGF Trap-Eye (BAY86-5321);   Other: Sham treatment
    Sponsors:   Bayer;   Regeneron Pharmaceuticals
    Recruiting - verified November 2009

  • Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled Asthma

    Condition:   Asthma
    Interventions:   Drug: Omalizumab;   Drug: Placebo
    Sponsor:   Novartis
    Recruiting - verified November 2009

  • Brain Computer Interface for Communication in ICU: a Feasibility Study

    Conditions:   Tetraplegia;   Guillain-Barre Syndrome
    Intervention:  
    Sponsor:   University of Versailles
    Not yet recruiting - verified October 2009

  • Safety and Efficacy Study of Kaname Coronary Stent System for the Treatment of Patients With Coronary Artery Disease

    Conditions:   Coronary Artery Disease;   Angioplasty, Transluminal, Percutaneous Coronary
    Intervention:   Device: Kaname cobalt-chromium coronary stent
    Sponsor:   Terumo Europe N.V.
    Not yet recruiting - verified October 2009

  • A Study to Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS)

    Condition:   Pneumonia
    Interventions:   Drug: Amikacin (BAY41-6551);   Drug: Amikacin (BAY41-6551);   Drug: Placebo
    Sponsors:   Bayer;   Nektar Therapeutics
    Completed - verified October 2009

  • An Exploratory Study to Assess the Effects of JNJ-39439335 on the Relief of Pain Using a Thermal-Grill Experimental Model

    Condition:   Pain
    Intervention:   Drug: JNJ-39439335, Placebo
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Not yet recruiting - verified November 2009

  • Phase IIa Study of MP4OX in Hemorrhagic Shock Patients With Lactic Acidosis

    Conditions:   Shock, Hemorrhagic;   Shock, Traumatic;   Acidosis, Lactic
    Interventions:   Drug: MP4OX;   Drug: MP4OX;   Drug: Ringer's Lactate solution
    Sponsor:   Sangart
    Not yet recruiting - verified November 2009

  • Gastric Bypass and Peripheral Activity of the Endocannabinoid System

    Condition:   Obesity
    Interventions:   Biological: Evaluation of the endocannabinoid system;   Procedure: Biopsy of visceral and peripheral adipose tissue;   Biological: Evaluation of metabolic parameters;   Behavioral: Evolution of behavioral parameters;   Behavioral: Dietician consultation;   Behavioral: Psychologist consultation
    Sponsors:   University Hospital, Bordeaux;   Institut National de la Santé Et de la Recherche Médicale, France
    Recruiting - verified November 2009

  • Computerized Glucose Control in Critically Ill Patients

    Conditions:   Hyperglycemia;   Critical Illness
    Interventions:   Device: CGAO-based Glucose Control;   Device: Standard-Care Glucose Control
    Sponsors:   Centre Hospitalier of Chartres;   Société Française d'Anesthésie et de Réanimation (SFAR);   Baxter Healthcare Corporation
    Recruiting - verified November 2009

  • The Occlusive Dressing

    Condition:   Fingertips Traumatic Amputations
    Interventions:   Other: TEGADERM®;   Procedure: Surgery
    Sponsor:   University Hospital, Strasbourg, France
    Not yet recruiting - verified October 2009

  • Effect of Preliminary Administration of Cyclosporine (Sandimmun ®) on Different Markers of Cardiac Ischaemia Induced by Cardiopulmonary Bypass

    Conditions:   Coronary Artery Bypass Surgery;   Cardiopulmonary Bypass
    Interventions:   Drug: Sandimmum;   Drug: Placebo
    Sponsor:   University Hospital, Grenoble
    Recruiting - verified November 2009

  • Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: infliximab, etanercept, adalimumab;   Drug: abatacept, rituximab or tocilizumab
    Sponsor:   University Hospital, Strasbourg, France
    Not yet recruiting - verified October 2009

  • Efficacy and Safety of Aclidinium Bromide at Two Dose Levels Versus Placebo Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients

    Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: Aclidinium bromide;   Drug: Placebo
    Sponsors:   Almirall S.A.;   Forest Laboratories
    Recruiting - verified November 2009

  • A Study Evaluating the Activity, Safety and Pharmacology of Two Doses of IPH2101, a Human Monoclonal Anti-KIR Antibody, in Patients With Multiple Myeloma in Stable Partial Response After a First Line Therapy

    Condition:   Multiple Myeloma
    Intervention:   Drug: IPH2101 Fully human anti-KIR monoclonal antibody
    Sponsor:   Innate Pharma
    Recruiting - verified November 2009

  • A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer

    Condition:   Non Small Cell Lung Cancer
    Interventions:   Drug: Pemetrexed;   Drug: Cisplatin;   Radiation: Thoracic Radiotherapy
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy Simulator

    Conditions:   Prostatic Neoplasms;   Cancer of Prostate;   Prostate Cancer;   Prostate Neoplasms
    Interventions:   Procedure: Laparoscopic Radical Prostatectomy (without a simulator) - no intervention;   Procedure: Laparoscopic Radical Prostatectomy (with a simulator)
    Sponsor:   Assistance Publique - Hôpitaux de Paris
    Not yet recruiting - verified October 2009

    • Menu
    Find Paid Clinical Trials